GCL SI Showcases Scenario-Based PV Solutions at SNEC 2026, Driving Application-Specific Solar Deployment and Low-Carbon Development
SHANGHAI, June 12, 2026 /PRNewswire/ -- GCL System Integration Technology Co., Ltd. ("GCL SI" or "the Company") has showcased its scenario-based PV solutions at the SNEC 2026 which was held in Shanghai, China from June 3 to 5. GCL SI showcased a...
THE GROWHUB LIMITED Announces Receipt of Nasdaq Staff Determination Letter and Intention to Request Hearing
SINGAPORE, June 10, 2026 /PRNewswire/ -- THE GROWHUB LIMITED (NASDAQ: TGHL) ("GrowHub" or the "Company"), a Singapore-based company leveraging blockchain technology to enhance product traceability and authenticity, today announced that it received a...
Dong Bang Co Ltd Strengthens Global Competitiveness with Advanced Veterinary Pharmaceuticals
SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dong Bang Co Ltd is strengthening its position in the global veterinary pharmaceutical market with high-value products including pet anesthetics and livestock reproductive hormones. Since its...
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
Oral presentation of DZD6008 demonstrated strong and durable anti-tumor activity, excellent BBB-penetrant properties, and a favorable safety profile in patients relapsed from third-generation EGFR TKI In treatment-naive patients with advanced NSCLC...
Makuake Hit Product UWANT Flagship V800 Vacuum Officially Launches on Amazon Japan
TOKYO, May 22, 2026 /PRNewswire/ -- UWANT, a professional brand focused on cleaning appliances, has officially launched its flagship anti-hair tangle self-emptying vacuum cleaner "UWANT V800" on Amazon Japan following its breakout success on...
Phase II Data from a Randomized Double-Blind Trial of Ligufalimab (Anti-CD47) Combination Therapy in Frontline AML Published at EHA 2026
HONG KONG, May 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) will be...
ACROBiosystems and SeromYx Systems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies
TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ -- ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collaboration with SeromYx Systems, specializing...
Copyright Enforcement Dialogue 2026 in Taipei Reinforces Regional Public-Private Cooperation Against Digital Piracy
TAIPEI, April 23, 2026 /PRNewswire/ -- On April 22, 2026, the Motion Picture Association (MPA) Asia Pacific concluded the Copyright Enforcement Dialogue: Taipei 2026, convening senior policymakers, law enforcement authorities, judicial...
Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth
SHANGHAI, April 22, 2026 /PRNewswire/ -- Hengrui Pharma reported steady growth in the first quarter of 2026. In Q1 2026, the Company recorded revenue of RMB 8.14 billion, up 12.98% year-over-year, while net profit attributable to shareholders...
Xinhua Silk Road: Traceability & anti-counterfeiting help ensure reliable quality of green tea in Rizhao
BEIJING, April 14, 2026 /PRNewswire/ -- In Rizhao, one of the world's three major coastal green tea cities, a complete tea industry chain traceability and anti-counterfeiting system is helping the eastern China locality ensure superb quality of...